Bli medlem
Bli medlem

Du är här


DENTSPLY International Inc.: DENTSPLY International Announces Lab Restructuring

York, PA - May 26, 2015
- DENTSPLY International Inc. (NASDAQ-XRAY), a global leader in professional
dental products, today announced that it has reached agreement with the
applicable works councils in Germany to proceed with restructuring portions
of its laboratory business, consistent with its earlier announcement of
September 17, 2014. The realignment of the lab business is designed to
increase emphasis on innovative prosthetic materials while exiting portions
of the lab equipment and fabrication businesses. The majority of this
restructuring effort will be implemented during the remainder of fiscal 2015
and 2016.

The Company expects to incur total costs in the range of $33 to $38 million
related to this initiative, the majority of which are expected to be recorded
in the fiscal second quarter of 2015. It is anticipated that approximately
85% of these costs will be cash outlays, including costs related to severance
and employee related obligations. This initiative impacts certain
manufacturing operations from two sites in Germany, one of which will be
closed and another that will be downsized. The Company noted that this
action is part of its broader efficiency program and the anticipated impact
was included in the adjusted earnings guidance as previously provided (which
excludes restructuring charges).

DENTSPLY International Inc. is a leading manufacturer and distributor of
dental and other consumable medical device products. For over 115 years,
DENTSPLY's commitment to innovation and professional collaboration has
enhanced its portfolio of branded consumables and small equipment.
Headquartered in the United States, the Company has global operations with
sales in more than 120 countries. Visit for more
information about DENTSPLY and its products.

This press release contains forward-looking information (within the meaning of
the Private Securities Litigation Reform Act of 1995) regarding future events
or the future financial performance of the Company that involve substantial
risks and uncertainties. Actual events or results may differ materially from
those in the projections or other forward-looking information set forth
herein as a result of certain risk factors. These risk factors include,
without limitation; the continued strength of dental and medical markets, the
timing, success and market reception for our new and existing products,
uncertainty with respect to governmental actions with respect to dental and
medical products, outcome of litigation and/or governmental enforcement
actions, volatility in the capital markets or changes in our credit ratings,
continued support of our products by influential dental and medical
professionals, our ability to successfully integrate acquisitions, risks
associated with foreign currency exchange rates, risks associated with our
competitors' introduction of generic or private label products, our ability
to accurately predict dealer and customer inventory levels, our ability to
successfully realize the benefits of any cost reduction or restructuring
efforts, our ability to obtain a supply of certain finished goods and raw
materials from third parties and changes in the general economic environment
that could affect the business. Changes in such assumptions or factors could
produce significantly different results.

For additional information regarding the factors that may cause actual results
to differ materially from these forward-looking statements, please refer to
the Company's most recent Form 10-K and its subsequent periodic reports on
Forms 10-Q filed with the Securities and Exchange Commission.

For further information contact:
Derek Leckow

Vice President

Investor Relations

(717) 849-7863



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DENTSPLY International Inc. via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.